Ultimovacs

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

Total raised

€28M

€27,713,597

Funding rounds

Investors

distinct backers

Active since

2021-10

latest 2021-10

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood15

base rate 38% for Growth/Late

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2021-10-26	Growth/Late	€28M	—	View deal →

same sector or country